Streetbeat News

Revenues

MEDS

TRxADE Health's subsidiary, Superlatus PD Holding Company, has entered into a supplier agreement with Rainforest Distribution Corp. The partnership will allow Superlatus to introduce its products to over 5,000 retail locations, including Whole Foods, Kroger, and more. The collaboration is expected to provide revenue growth and expansion opportunities for Superlatus's Consumer Package Goods portfolio.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 12:09 pm

VTAK

Catheter Precision's VIVO, a cardiac mapping system, is now eligible for national reimbursement in the U.K. This could potentially increase the product's sales and usage in the country.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 12:05 pm

DOX

Amdocs Limited (NASDAQ:DOX) has issued a statement regarding the recent events in Israel, stating that they do not expect these events to materially adversely affect their business. The company's revenue from customers in Israel comprises less than 0.5% of total revenue, and the majority of their employees are located outside of Israel.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 12:04 pm

INFY

Infosys Ltd reported Q2 revenue growth of 3.6% YoY to $4.72 billion, beating the consensus of $4.61 billion. However, the operating margin declined by 30 bps to 21.2%. The company held $4.17 billion in cash and equivalents and clocked a free cash flow of $670 million. The Board announced an interim dividend of ₹18 per share, an increase of 9.1% over last year. Despite this, Infosys cut its FY24 revenue outlook, expecting growth of 1.0% - 2.5% in constant currency, down from the prior 1.0% - 3.5%.

Portfolio Pulse from Anusuya Lahiri

October 12, 2023 | 11:59 am

MSFT

OpenAI, the parent company of ChatGPT, is planning to introduce significant enhancements for developers to reduce the cost and increase the speed of creating software applications. The updates include introducing memory storage to developer tools and vision capabilities. These innovations could potentially cut expenses by up to 20 times. OpenAI, backed by Microsoft Corp, is transitioning from being a consumer hit to establishing a prominent developer platform. The company aims to generate over $1 billion in revenue over the next 12 months from selling artificial intelligence software and computing capacity.

Portfolio Pulse from Anusuya Lahiri

October 12, 2023 | 11:44 am

QDEL

QuidelOrtho has reported preliminary Q3 revenues of $738M-$744M, surpassing the consensus of $655.33M. The non-respiratory product revenue is expected to be $557M-$560M, while the respiratory product revenue is projected to be $181M-$184M.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 11:34 am

OFIX

Orthofix Medical has announced the 510K clearance and full commercial launch of OsteoCove, an advanced bioactive synthetic graft. This development could potentially boost the company's revenues and market share in the medical devices sector.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 11:30 am

HSDT

Helius Medical Technologies has received a letter of intent from the Québec Ministry of Health and Social Services to purchase 30 Portable Neuromodulation Stimulator devices. This could potentially increase the company's revenues.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 11:15 am

EVLV

Evolv Technology has announced preliminary Q3 revenues of $19.3M-$19.8M, surpassing the consensus of $16.86M. The company also raised its FY23 outlook to $75M-$77M, higher than the $73.74M consensus.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 11:10 am

OSCR

Oscar Health has announced its expansion into 165 new markets across 13 states through its Individual & Family Plans. This move is expected to increase the company's market reach and potentially boost its revenues.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 10:58 am